Antimicrobial Susceptibility Testing for Three Malassezia Species

Brooke Rathie, Bart Theelen, Martin Laurence, Rebecca S. Shapiro

Research output: Contribution to journalArticlepeer-review

Abstract

The Malassezia genus comprises lipid-dependent yeasts that have long been associated with common skin diseases, and have recently been linked with Crohn's disease and certain cancers. Understanding Malassezia susceptibility to diverse antimicrobial agents is crucial for identifying effective antifungal therapies. Here, we tested the efficacy of isavuconazole, itraconazole, terbinafine, and artemisinin against three Malassezia species: M. restricta, M. slooffiae, and M. sympodialis. Using broth microdilution, we found antifungal properties for the two previously unstudied antimicrobials: isavuconazole and artemisinin. Overall, all Malassezia species were particularly susceptible to itraconazole, with a MIC range from 0.007 to 0.110 μg/mL.

Original languageEnglish (US)
JournalMicrobiology Spectrum
Volume11
Issue number4
DOIs
StatePublished - Aug 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 Rathie et al.

Keywords

  • antifungals
  • antimicrobial resistance
  • Malassezia

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Antimicrobial Susceptibility Testing for Three Malassezia Species'. Together they form a unique fingerprint.

Cite this